000 01032 a2200253 4500
005 20250513160555.0
264 0 _c19990204
008 199902s 0 0 eng d
022 _a1351-8216
024 7 _a10.1046/j.1365-2516.1998.00158.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCourter, S G
245 0 0 _aCall for post-licensing human pharmacokinetic studies of administration of recombinant factor IX.
_h[electronic resource]
260 _bHaemophilia : the official journal of the World Federation of Hemophilia
_cMar 1998
300 _a136-7 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aFactor IX
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aRecombinant Proteins
_xpharmacokinetics
700 1 _aBeach, K J
773 0 _tHaemophilia : the official journal of the World Federation of Hemophilia
_gvol. 4
_gno. 2
_gp. 136-7
856 4 0 _uhttps://doi.org/10.1046/j.1365-2516.1998.00158.x
_zAvailable from publisher's website
999 _c9836271
_d9836271